Background Prehospital delays remain critical barriers to timely acute coronary syndrome (ACS) care, particularly for ...
In this retrospective cohort analysis, researchers aimed to identify key predictors of trial enrollment among cancer patients.
MedPage Today on MSN
Real-World Data Show Gout Treatment Disparities
In a 10-year propensity-matched cohort study, Irene Tan, MD, of the Einstein Healthcare Network and Jefferson Health in ...
Preliminary but promising.Those three words emerged as a recurring theme in conversations about several abstracts presented at this year’s ASH Annual Meeting and Exposition that examined the effects ...
Adults with type 2 diabetes who have hypertension before 45 years of age have higher risks for cardiovascular disease, ...
Use of liraglutide or semaglutide therapy does not increase risk for thyroid cancer among patients with type 2 diabetes or obesity.
Chronic kidney disease (CKD) severity is associated with an increased risk for gastroparesis, according to a study published ...
The target trial emulation study suggests rigid risk thresholds aren’t needed to steer statin use in this group.
Benefits of GLP-1 RAs were consistent across age groups and BMI categories, with semaglutide showing significant efficacy. These results were presented during the press briefing ahead of the 2026 ...
Results showed collared fully hydroxyapatite-coated femoral components had lower rates of postoperative periprosthetic ...
New evidence shows GnRH antagonist stimulation outperforms PPOS for oocyte yield in young high-risk IVF patients, supporting ...
Findings of reduced risks for mortality and major CVD suggest consideration of statins in all adults with type 2 diabetes, even in those with low short-term predicted CVD risk.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results